(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.10%) $82.55
(1.03%) $2.05
(-0.50%) $2 346.00
(-0.90%) $27.41
(0.01%) $961.60
(0.09%) $0.933
(0.19%) $11.00
(0.06%) $0.796
(0.01%) $93.31
1.38% ¥ 6 458.00
Live Chart Being Loaded With Signals
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses...
Stats | |
---|---|
Dagens volum | 284 900 |
Gjennomsnittsvolum | 1.10M |
Markedsverdi | 3 504.67B |
EPS | ¥0 ( 2024-02-13 ) |
Neste inntjeningsdato | ( ¥122.99 ) 2024-05-09 |
Last Dividend | ¥50.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 28.80 |
ATR14 | ¥8.92 (0.14%) |
Volum Korrelasjon
Otsuka Holdings Co., Ltd. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Otsuka Holdings Co., Ltd. Korrelasjon - Valuta/Råvare
Otsuka Holdings Co., Ltd. Økonomi
Annual | 2023 |
Omsetning: | ¥2 018.57B |
Bruttogevinst: | ¥1 407.35B (69.72 %) |
EPS: | ¥224.11 |
FY | 2023 |
Omsetning: | ¥2 018.57B |
Bruttogevinst: | ¥1 407.35B (69.72 %) |
EPS: | ¥224.11 |
FY | 2022 |
Omsetning: | ¥1 738.00B |
Bruttogevinst: | ¥1 168.50B (67.23 %) |
EPS: | ¥246.81 |
FY | 2021 |
Omsetning: | ¥1 498.28B |
Bruttogevinst: | ¥1 003.25B (66.96 %) |
EPS: | ¥231.35 |
Financial Reports:
No articles found.
Otsuka Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥50.00 (N/A) |
¥0 (N/A) |
¥50.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥28.00 | 2011-03-29 |
Last Dividend | ¥50.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 27 | -- |
Total Paid Out | ¥1 121.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.85 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.03 | |
Div. Directional Score | 8.61 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8117.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7458.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6676.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6005.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4709.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3940.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3166.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2139.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9024.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
7915.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0602 | 1.500 | 8.80 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0362 | 1.200 | 8.79 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0508 | 1.500 | -0.547 | -0.821 | [0.1 - 1] |
payoutRatioTTM | 0.458 | -1.000 | 5.42 | -5.42 | [0 - 1] |
currentRatioTTM | 1.989 | 0.800 | 5.06 | 4.05 | [1 - 3] |
quickRatioTTM | 1.533 | 0.800 | 5.69 | 4.55 | [0.8 - 2.5] |
cashRatioTTM | 0.769 | 1.500 | 6.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0468 | -1.500 | 9.22 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 37.62 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0658 | -1.500 | 9.74 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.697 | 1.000 | 1.713 | 1.713 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.126 | 1.000 | 9.49 | 9.49 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.799 | 1.000 | 1.119 | 1.119 | [0.2 - 2] |
assetTurnoverTTM | 0.601 | 0.800 | 9.33 | 7.46 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 28.43 | 1.000 | 7.23 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0508 | 2.50 | -0.352 | -0.821 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.727 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.458 | 1.500 | 5.42 | -5.42 | [0 - 1] |
pegRatioTTM | 1.320 | 1.500 | 4.53 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.140 | 1.000 | 8.99 | 0 | [0.1 - 0.5] |
Total Score | 6.03 |
Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.